SCHEMBL4006463

SCHEMBL4006463

CCN1CCC(Oc2ccc3c(N)nccc3c2)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 9/20 0.72
ROCK2 O75116 3/20 0.59
KCNH2 Q12809 2/20 0.59
HRH3 Q9Y5N1 4/20 0.48
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
CCR2 P41597 1/20 0.39
SRC P12931 2/20 0.39
CSF1R P07333 1/20 0.39
FLT3 P36888 1/20 0.39
FGFR1 P11362 1/20 0.38
PDGFRA P16234 1/20 0.38
FLT1 P17948 1/20 0.38
KDR P35968 1/20 0.38
KLKB1 P03952 1/20 0.38
KLK1 P06870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4005996 0.86 ROCK1 (0.69) ROCK1ROCK2KCNH2HRH3MAOA
SCHEMBL8939214 0.86 ROCK1 (0.54) ROCK1ROCK2KCNH2HRH3KDM4E
SCHEMBL4008293 0.84 ROCK1 (1.00) ROCK1ROCK2KCNH2HRH3MAOA
SCHEMBL4006130 0.82 ROCK1 (0.64) ROCK1ROCK2KCNH2FGFR1KLKB1
SCHEMBL4006134 0.82 ROCK1 (0.64) ROCK1ROCK2KCNH2FGFR1KLKB1
SCHEMBL4006160 0.80 ROCK1 (0.89) ROCK1ROCK2KCNH2HRH3MAOA
SCHEMBL4007373 0.80 ROCK1 (0.89) ROCK1ROCK2KCNH2HRH3MAOA
SCHEMBL4006165 0.80 ROCK1 (0.89) ROCK1ROCK2KCNH2HRH3MAOA
SCHEMBL1204561 0.80 ROCK1 (0.74) ROCK1ROCK2KCNH2KLKB1
SCHEMBL3113476 0.80 ROCK1 (0.74) ROCK1ROCK2KCNH2KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963304-B2 ISOQUINOLINE DERIVATIVES MSD OSS BV (NL) 2015-05-13 EP disclosed
US-7618985-B2 Isoquinoline derivatives N.V. ORGANON (NL) 2009-11-17 US disclosed
EP-1963304-B1 ISOQUINOLINE DERIVATIVES ORGANON NV (NL) 2009-06-24 EP disclosed
EP-1963304-A1 ISOQUINOLINE DERIVATIVES N.V. Organon (NL) 2008-09-03 EP disclosed
WO-2007065916-A1 ISOQUINOLINE DERIVATIVES N.V. ORGANON (NL) 2007-06-14 WO disclosed
US-20070135479-A1 Isoquinoline derivatives N.V. ORGANON (NL) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135479-A1 Isoquinoline derivatives ROCK1, ROCK2, RHOA ROCK1 1/4885ROCK2 2/4885KCNH2 343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.